[Advantages and limitations of the galactosamine model].
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004195:Disease Models, Animal; D005688:Galactosamine; D005943:Gluconeogenesis / Q000187:drug effects; D006017:Glycolipids / Q000096:biosynthesis; D006023:Glycoproteins / Q000096:biosynthesis; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D014500:Uracil Nucleotides / Q000378:metabolism
D006017:Glycolipids; D006023:Glycoproteins; D014500:Uracil Nucleotides; D012313:RNA; D005688:Galactosamine
Nutzen und Grenzen des Galaktosamin-Modells.